Determination of spectroscopy marker of atherosclerotic carotid stenosis using FTIR-ATR combined with machine learning and chemometrics analyses

IF 4.2 2区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Nanomedicine : nanotechnology, biology, and medicine Pub Date : 2024-09-26 DOI:10.1016/j.nano.2024.102788
Jan Jakub Kęsik PhD , Wiesław Paja PhD , Pawel Jakubczyk Prof. , Maryna Khalavka PhD , Piotr Terlecki Prof. , Marek Iłżecki PhD. , Wioletta Rzad MSc , Joanna Depciuch PhD
{"title":"Determination of spectroscopy marker of atherosclerotic carotid stenosis using FTIR-ATR combined with machine learning and chemometrics analyses","authors":"Jan Jakub Kęsik PhD ,&nbsp;Wiesław Paja PhD ,&nbsp;Pawel Jakubczyk Prof. ,&nbsp;Maryna Khalavka PhD ,&nbsp;Piotr Terlecki Prof. ,&nbsp;Marek Iłżecki PhD. ,&nbsp;Wioletta Rzad MSc ,&nbsp;Joanna Depciuch PhD","doi":"10.1016/j.nano.2024.102788","DOIUrl":null,"url":null,"abstract":"<div><div>Atherosclerotic carotid stenosis (ACS) is a recognized risk factor for ischemic stroke. Currently, the gold diagnostic standard is Doppler ultrasound, the results of which do not provide certainty whether a given person should be qualified for surgery or not, because in some patients, carotid artery stenosis, for example at the level of 70 %, does not cause ischemic stroke in others yes. Therefore, there is a need for new methods that will clearly indicate the marker qualifying the patient for surgery. In this article we used Fourier Transform InfraRed Attenuated Total Reflectance (FTIR-ATR) spectra of serum collected from healthy and patients suffering from ACS, which had surgery were analyzed by machine learning and Principal Component Analysis (PCA) to determine chemical differences and spectroscopy marker of ACS. PCA demonstrated clearly differentiation between serum collected from healthy and non-healthy patients. Obtained results showed that in serum collected from ACS patients, higher absorbances of PO<sup>2−</sup> stretching symmetric, CH<sub>2</sub> and CH<sub>3</sub> symmetric and asymmetric and amide I vibrations were noticed than in control group. Moreover, lack of peak at 1106 cm<sup>−1</sup> was observed in spectrum of serum from non-control group. As a result of spectral shifts analysis was found that the most important role in distinguishing between healthy and unhealthy patients is played by FTIR ranges caused by vibrations of PO<sup>2−</sup> phospholipids, amides III, II and C<img>O lipid vibrations. Continuing, peaks at 1636 cm<sup>−1</sup> and 2963 cm<sup>−1</sup> were proposed as a potential spectroscopy markers of ACS. Finally, accuracy of obtained results higher than 90 % suggested, that FTIR-ATR can be used as an additional diagnostic tool in ACS qualifying for surgery.</div></div>","PeriodicalId":19050,"journal":{"name":"Nanomedicine : nanotechnology, biology, and medicine","volume":"62 ","pages":"Article 102788"},"PeriodicalIF":4.2000,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanomedicine : nanotechnology, biology, and medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1549963424000571","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Atherosclerotic carotid stenosis (ACS) is a recognized risk factor for ischemic stroke. Currently, the gold diagnostic standard is Doppler ultrasound, the results of which do not provide certainty whether a given person should be qualified for surgery or not, because in some patients, carotid artery stenosis, for example at the level of 70 %, does not cause ischemic stroke in others yes. Therefore, there is a need for new methods that will clearly indicate the marker qualifying the patient for surgery. In this article we used Fourier Transform InfraRed Attenuated Total Reflectance (FTIR-ATR) spectra of serum collected from healthy and patients suffering from ACS, which had surgery were analyzed by machine learning and Principal Component Analysis (PCA) to determine chemical differences and spectroscopy marker of ACS. PCA demonstrated clearly differentiation between serum collected from healthy and non-healthy patients. Obtained results showed that in serum collected from ACS patients, higher absorbances of PO2− stretching symmetric, CH2 and CH3 symmetric and asymmetric and amide I vibrations were noticed than in control group. Moreover, lack of peak at 1106 cm−1 was observed in spectrum of serum from non-control group. As a result of spectral shifts analysis was found that the most important role in distinguishing between healthy and unhealthy patients is played by FTIR ranges caused by vibrations of PO2− phospholipids, amides III, II and CO lipid vibrations. Continuing, peaks at 1636 cm−1 and 2963 cm−1 were proposed as a potential spectroscopy markers of ACS. Finally, accuracy of obtained results higher than 90 % suggested, that FTIR-ATR can be used as an additional diagnostic tool in ACS qualifying for surgery.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
利用傅立叶变换红外-ATR 结合机器学习和化学计量学分析确定动脉粥样硬化性颈动脉狭窄的光谱标记。
动脉粥样硬化性颈动脉狭窄(ACS)是公认的缺血性中风的危险因素。目前,黄金诊断标准是多普勒超声检查,但其结果并不能确定某人是否符合手术条件,因为有些患者的颈动脉狭窄程度(例如 70%)不会导致缺血性中风,而有些患者的颈动脉狭窄程度(例如 70%)则会导致缺血性中风。因此,我们需要新的方法来明确指出患者是否符合手术条件。在本文中,我们使用傅立叶变换红外衰减全反射(FTIR-ATR)光谱分析了从健康人和接受过手术的 ACS 患者采集的血清,并通过机器学习和主成分分析(PCA)确定了 ACS 的化学差异和光谱标记。主成分分析清楚地显示了健康和非健康患者血清之间的差异。结果显示,与对照组相比,采集自 ACS 患者的血清中 PO2-对称伸展、CH2 和 CH3 对称和不对称以及酰胺 I 振动的吸光度更高。此外,在非对照组血清的光谱中没有发现 1106 cm-1 处的峰值。光谱移动分析结果表明,傅立叶变换红外光谱中,PO2-磷脂振动、酰胺 III、II 和 CO 脂质振动在区分健康和不健康患者中起着最重要的作用。此外,1636 cm-1 和 2963 cm-1 的峰值被认为是 ACS 的潜在光谱标记。最后,傅立叶变换红外-ATR 结果的准确率高于 90%,这表明傅立叶变换红外-ATR 可用作 ACS 手术资格的额外诊断工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
11.10
自引率
0.00%
发文量
133
审稿时长
42 days
期刊介绍: The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine. Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life and health sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.
期刊最新文献
Comparison of cholesterol transport capacity of peptide- and polymer-based lipid Nanodiscs Retraction notice to “In vitro angiogenic performance and in vivo brain targeting of magnetized endothelial progenitor cells for neurorepair therapies” [Nanomedicine: Nanotechnology, Biology and Medicine 10/1 (2014) 225–234] Facile fabrication of nano-bioactive glass functionalized blended hydrogel with nucleus pulposus-derived MSCs to improve regeneration potential in treatment of disc degeneration by in vivo rat model. Micellar curcumol for maintenance therapy of ovarian cancer by activating the FOXO3a Conceptual rationale for the use of chemically modified nanocomposites for active influence on atherosclerosis using the greater omentum model of experimental animals
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1